CAR-T cell therapy is a whole new dimension in cancer treatment where T-cells are repurposed to recognize and destroy cancerous cells more effectively. In this variant of cellular therapy, T-cells are genetically modified to express a chimeric antigen receptor, CAR, on their surface; thus, these receptors enable the T-cells to locate certain types of proteins on cancerous cells. The modified T-cells will seek and bind to cancer cells, prompting an immune response that destroys the malignant cells. CAR-T therapeutics represent the leading edge in modern cancer treatment, offering a hopeful and very personalized approach.
Comments are closed.